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Background: This retrospective study aims to identify clinical predictors of intraoperative blood loss 
during lung transplantation. While for other surgical specialties predictors of blood loss have been identified 
such as previous likewise located surgery, poor preoperative health status of patients, blood coagulation 
status, and use of extra corporeal circulation, predictors of blood loss during lung transplantation are not yet 
established. 
Methods: A total of 326 lung transplants were performed between January 2000 and February 2014 at 
a tertiary hospital. The primary aim was to associate blood loss with the following potential predictors: 
pulmonary arterial hypertension, pre- or intraoperative extracorporeal life support (ECLS), previous thoracic 
surgery, previous lung transplant, and Charlson Comorbidity Index (CCI). Postoperative complications and 
30-day mortality were secondary endpoints of the study.
Results: Median estimated blood loss during lung transplant was 1,500 mL (IQR, 1,000–2,875 mL). 
Pre- and intraoperative ECLS (P=0.02, P<0.001) independently increased blood loss by 59% and 107%, 
respectively. The higher blood loss during re-transplant marginally missed the significance level (P=0.05). 
Pulmonary arterial hypertension, previous thoracic surgery and high CCI were not associated with increased 
blood loss. As secondary outcomes, postoperative complications were more common in patients with a 
higher blood loss (P=0.04) but was not associated with higher 30-day mortality (P=0.18).
Conclusions: Pre- and intraoperative ECLS were significant risk factors for higher blood loss during lung 
transplantation. Higher blood loss was associated with higher incidence of postoperative complications but 
not with a higher 30-day mortality.
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Introduction
Recent studies suggest that intraoperative blood loss—
associated with the necessity of blood transfusion—has a 
negative impact on patient outcome after major surgery 
(1-4). Previous surgery at the same site, poor preoperative 
health status of the patients, impaired blood coagulation, 
and the use of extra corporeal circulation play a decisive 
role in perioperative blood loss. Currently, no specific 
predictor of blood loss in lung transplantation is known (5). 
The aim of this retrospective study is to identify factors 
predictive of increased intraoperative blood loss during lung 
transplantation.
Considering recent relevant publications in other 
specialties, previous surgery at the same site was reported 
to be one of those factors (6-8). We therefore investigated 
the impact of previous thoracic surgery or previous lung 
transplantation on blood loss during lung transplantation. 
If possible, we preferred to examine continuous instead 
of categorical variables to depict the impact of a factor 
on blood loss. For example, we avoided setting disease as 
a variable, but the symptom causing blood loss, thus the 
impact of pulmonary arterial pressure on blood loss was 
investigated and not whether or not pulmonary arterial 
hypertension was present. 
Surgery under extracorporeal circulation (ECC) may be 
accompanied with blood loss due to heparin use, resulting 
in a prolonged activated clotting time (ACT) and reduced 
thrombus formation at the surgical site (9-11). While ECC 
is a requirement for urgent listing of patients, we preferred 
to highlight the fact whether or not ECC was present or 
not over the patients listing category. 
In multimorbid patients, perioperative complications, 
including hemorrhage, are common (12). This suggests that 
multimorbid patients may be susceptible for bleeding, also 
during lung transplantation. We measured comorbidities 
with the Charlson Comorbidity Index (CCI) (13).
Mechanistically thinking, an increased pulmonary 
artery pressure, might increase blood loss during lung 
transplantation.
The primary aim of this study was to assess predictors 
of blood loss during lung transplantation. The following 
factors were investigated: pre- and intraoperative ECC, pre-
existing pulmonary arterial hypertension, previous thoracic 
surgery, previous lung transplantation, and CCI.
The secondary aim was the association of increased 
blood loss with postoperative complications and 30-day 
mortality.
Methods
Study design and ethical approval
This study is a single center retrospective analysis of all 
patients who underwent lung transplantation between 
January 2000 and February 2014. The study was approved 
by the local ethics committee in January 2015 and carries 
the study number 2014-0579. According to the ethics 
approval, patient data could be evaluated, in case the patient 
did not explicitly refuse to have data collected for research 
purposes.
Data collection
The data were extracted from the patient’s electronical 
medical records (KISIM, Cistec, Zurich, Switzerland), 
where the complete patient history can be found. For 
blood loss estimations, we relied on the anesthesia protocol 
rather than on the surgical estimation in case the two were 
incongruent. The data has been analyzed according to the 
STROBE (STrengthening the Reporting of OBservational 
studies in Epidemiology) statement.
Statistical analyses
Continuous variables are presented as median and 
interquartile range (IQR) or mean ± standard deviation (SD). 
Categorical variables are presented as absolute numbers and 
percentage (%). Statistical analyses were performed using 
IBM SPSS Statistics (Version 22.0, IBM Corp, Armonk, 
NY, USA) and GraphPad Prism 6.0 (GraphPad Inc, La 
Jolla, CA, USA). In a univariate analysis, potential variables 
associated with blood loss were explored using the Mann-
Whitney test and Spearman rank correlations. Variables 
with P<0.2 were included into a stepwise linear regression 
analysis. For this analysis, blood loss was logarithmically 
transformed (base 10). Normal distribution of residuals 
was assessed visually using histograms and p-p plots. In 
the final model, relative increase of blood loss due to the 
included factors in percent are reported together with 95% 
confidence intervals (CIs). Two-sided P values <0.05 were 
considered statistically significant. 
Surgical methods
Organ preservation was performed with Perfadex® (Vitrolife, 
Gothenburg, Sweden). Before ante-grade flush, 500 µg 
prostaglandin E1 (Prostin VR, Upjohn, Puurs, Belgium) 
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was injected into the pulmonary artery in all cases. Retrieval 
of the donor lung was performed en bloc after perfusion. 
Retrograde flush with Perfadex® was performed during the 
back-table preparation. The decision to perform size-reduced 
lung transplantation was made on-site during implantation. 
For lobar transplants, lobectomy was made on the back-
table. The surgical site was reached through bilateral trans-
sternal anterior thoracotomy (clamshell incision) or two 
separate anterolateral thoracotomies. First, the bronchial 
anastomosis, followed by venous (atrial cuff), and pulmonary 
artery anastomosis were sutured. The recipient’s main 
bronchus was cut one ring proximal to the upper lobe 
bronchus branch. Bronchial arteries were ligated of the peri-
bronchial tissue without electro coagulation. All dissections 
on the bronchus were performed using “no touch” technique 
in order to keep the peri-bronchial tissue intact. The donor 
bronchus was cut back as close as possible to the origin of 
the upper lobe bronchus with special attention to the peri-
bronchial tissue. Absorbable suture material polydioxanone 
(PDS, Ethicon Inc., NJ, USA) was used. A continuous 
suture to the membranous wall (PDS, 4/0) and end-to-end 
anastomosis with interrupted single stitches (PDS, 4/0) to the 
cartilaginous part were performed (14).
Bilateral lung transplantation was performed in 96% of 
the cases. Due to size-mismatch of the donor and recipient 
height lobar lung transplantation was performed in 
97 cases (33.2%); bilateral lobar lung transplantation in 37 
and unilateral lobar lung transplantation in 60 cases. We 
used intraoperative extracorporeal life support (ECLS) 
in 139 (47.6%) transplantations. Twenty recipients 
were bridged to lung transplantation on extracorporeal 
membrane oxygenation (ECMO).
Results
Patient flow
At the University Hospital Zurich 326 lung transplants 
(17 of them were re-transplants) were performed between 
January 2000 and February 2014. From these, 34 could not 
be included into the analysis because blood loss was not 
documented. The final analysis included 292 cases (Figure 1). 
Patient and procedure characteristics 
Patients had a mean age of 46±16 years, a mean weight of 
62±18 kg, and a mean height of 167±9 cm. There were 154 
(52.7%) male and 138 (47.3%) female patients. Previous 
thoracic surgery was documented in 105 (36.0%), pulmonary 
hypertension in 171 (58.6%) cases. Twenty patients (6.8%) 
were on an ECLS prior to transplantation and 139 patients 
(47.6%) during transplant surgery. The median blood loss 
during the procedure was 1,500 mL (IQR, 1,000–2,875 mL). 
Details of the patient characteristics can be found in Table 1, 
and of the procedure characteristics in Table 2. 
Risk factors for blood loss during lung transplant
In a univariate analysis potential associations of factors 
contributing to hemorrhage have been evaluated: age, 
weight, height, body mass index (BMI), gender, pulmonary 
hypertension, preoperative mean pulmonary arterial 
pressure (mPAP), CCI, previous thoracic surgery, previous 
lung transplant, pre- and intraoperative ECC, the type of 
intraoperative ECC [ECMO or cardiopulmonary bypass 
(CPB)] (Table 3). The potentially associated factors, defined 
by P<0.2 in the univariate analysis, were preoperative 
mPAP, CCI, previous thoracic surgery, previous lung 
transplant, and preoperative and intraoperative ECC. 
These were included in a stepwise multivariate model 
(Table 4). We identified pre- and/or intraoperative ECLS 
(P=0.02, P<0.001 respectively, Figures 2,3) as risk factors for 
increased blood loss, retransplantation marginally failed the 
significance level for increased blood loss (P=0.05). There 
was no difference in intraoperative blood loss in patients 
with an ECMO or a CPB (Figure 3).
Previous intrathoracic surgery, a CCI and pulmonary 
hypertension were not associated with an increased blood loss. 
Secondary outcomes
Blood loss was associated with a higher number of patients 
suffering from a postoperative complication, occurring in 
181 (62.0%) cases (P=0.04), but was not associated with 
a higher 30-day mortality, occurring in 17 (5.8%) cases 
(P=0.18) (Table 5). 
326 transplants from 
01/2000 until 02/2014
292 cases in final analysis 34 transplants w/o documented blood loss
Figure 1 Case analysis.
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Discussion
This retrospective study reveals that both previous lung 
transplantation and pre- or an intraoperative ECLS are 
independent risk factors for increased blood loss in lung 
transplant surgery. In addition, we were able to demonstrate 
that a high blood loss is associated with a higher rate of 
postoperative complications.
Surprisingly, neither comorbidities nor an elevated mPAP 
at the beginning of the transplantation were associated with 
Table 2 Procedure characteristics
Character Value 
Blood loss (mL), median [IQR] 1,500 [1,000–2,875]
Necessity of ECLS preoperatively, n (%) 20 (6.8)
Necessity of ECLS intraoperatively, n (%) 139 (47.6)
ECMO 129 (44.2)
Classic cardiopulmonary bypass 10 (3.4)
IQR, interquartile range; ECLS, extracorporeal life support 
device; ECMO, extracorporeal membrane oxygenation. 
Table 1 Patient characteristics
Character Value
Age (years) 46±16
Weight (kg) 62±18
Sex, n (%)
Male 154 (52.7)
Female 138 (47.3)
Preoperative mPAP (mmHg) 31±13
Previous thoracic surgery, n (%) 105 (36.0)
Once 86 (29.5)
Twice 12 (4.1)
Three times 4 (1.4)
Four times 1 (0.3)
Five times 2 (0.7)
Previous lung transplant, n (%) 16 (5.5)
Charlson Comorbidity Index, n (%)
1 177 (60.6)
2 66 (22.6)
3 31 (10.6)
4 8 (2.7)
5 2 (0.7)
6 2 (0.7)
7 4 (1.4)
8 1 (0.3)
9 1 (0.3)
mPAP, mean pulmonary artery pressure.
Table 3 Univariate analysis of associations with blood loss during 
lung transplant surgery
Factor P value
Age 0.79
Weight 0.54
Height 0.51
BMI 0.71
Gender 0.93
Pulmonary hypertension (mPAP >25 mmHg) 0.24
Preoperative mPAP 0.04
CCI 0.06
Previous thoracic surgery 0.18
Previous lung transplant 0.02
ECC preoperative <0.001
ECC intraoperative <0.001
Type of intraoperative ECC (CPB or ECMO) 0.22
BMI, body mass index; mPAP, mean pulmonary artery pressure; 
CCI, Charlson Comorbidity Index; ECC, extracorporeal circulation; 
CPB, cardiopulmonary bypass; ECMO, extracorporeal membrane 
oxygenation.
Table 4 Multivariate analysis of factors associated with blood loss 
during lung transplant surgery
Factor Relative increase (95% CI) P value
ECC intraoperative 107% (72% to 150%) <0.001
ECC preoperative 59% (7% to 136%) 0.02
Previous lung transplant 50% (1% to 124%) 0.05
ECC, extracorporeal circulation.
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increased hemorrhage. The 30-day mortality seems to be 
unaffected by the amount of blood loss, but the number of 
cases was low and therefore the study may lack the power 
for this outcome.
It is interesting to note that the use of intraoperative 
ECC was associated with increased blood loss, but there 
was no difference between the use of an ECMO (using 
only a low dose heparinization with a target ACT of 150 
to 180 s) and the use of a heart-lung machine (HLM) 
(using full heparinization with a higher target ACT of 250 
to 300 s). We cannot exclude, that besides heparinization 
other factors might have impact on blood loss, such as 
surgical techniques or a different patient population in the 
two groups. Comparing ECMO and HLM, recent studies 
focused only on transfusion requirements but not on blood 
loss. Concerning transfusion requirements ECMO seems 
to be the better option (15-17) but two studies report 
otherwise (18,19). However, Burdett et al. investigated 
blood loss in single lung transplants with and without the 
use of CPB and found significantly greater blood loss in 
the CPB group (20).
The identification of factors for increased intraoperative 
blood loss is interesting from various points of view: on 
one hand, this knowledge might serve as a criterion for 
or against listing patients who otherwise appear marginal 
and might therefore be at risk for not surviving the 
transplantation. On the other hand, known risk factors 
could help to be alert for blood loss and for early and even 
more stringent coagulation management and cell salvage.
Finally, to minimize blood loss in patients at high risk 
for elevated intraoperative blood loss, the most experienced 
surgeon should be in charge for the critical surgical steps.
Limitations
In addition to the usual problems of being a retrospective 
analysis, the investigation has been limited to a single center. 
The selection of patients has been different over time. At 
Figure 2 Blood loss with and without preoperative ECLS. ECLS, 
extracorporeal life support; ECC, extracorporeal circulation.
Figure 3 Blood loss with intraoperative HLM and ECMO 
and without ECC. ECC, extracorporeal circulation; ECMO, 
extracorporeal membrane oxygenation; HLM, heart-lung machine.
Table 5 Secondary outcomes associated with blood loss during lung 
transplant surgery (univariate analysis)
Secondary outcome P value
Death within 30 days 0.18
Postoperative complications 0.04
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first, patients with a simple anatomy and selective organs 
(to avoid a size mismatch) were chosen, which might have 
facilitated the procedure and minimized blood loss, whereas 
towards the end of the observation period more complex 
patients have been on the transplant list. Furthermore, the 
practice, indication and use of ECLS have become more 
liberal and frequent throughout the study period.
Conclusions
Previous lung transplant as well as pre- and intraoperative 
treatment with ECLS are independent factors for increased 
blood loss in lung transplantation, which is associated with 
increased complication rate, but not with increased 30-day 
mortality.
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